News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

China Resources Pharmaceutical Starts Trading Following $1.8 Billion IPO



10/31/2016 10:50:56 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Following its $1.8 billion IPO, China Resources Pharmaceutical Group began trading on the Hong Kong exchange. In the first trading session, the stock dropped about 1% to HK$9.01 from its offering price of HK$9.10, the middle of the offering range. CR Pharma priced its IPO at a modest 14.5 times earnings. The company is part of the larger state-owned China Resources conglomerate, and it, in turn, is parent to three China-listed pharmas. CR Pharma is China's second-largest drugmaker, with extensive holdings in drug manufacturing (both western and TCM) plus its large China drug distribution operation.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES